Redwood Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-73,444
Closed -$1.21M 111
2024
Q4
$1.21M Sell
73,444
-97
-0.1% -$1.51K 0.32% 82
2024
Q3
$1.08M Sell
73,541
-18,326
-20% -$287K 0.32% 88
2024
Q2
$1.27M Sell
91,867
-28,269
-24% -$401K 0.43% 79
2024
Q1
$1.86M Sell
120,136
-28,128
-19% -$434K 0.54% 72
2023
Q4
$2.4M Buy
+148,264
New +$2.43M 0.63% 71
2022
Q1
Sell
-335,054
Closed -$11.4M 136
2021
Q4
$11.4M Sell
335,054
-3,256
-1% -$128K 0.9% 42
2021
Q3
$16.3M Sell
338,310
-20,245
-6% -$937K 1.36% 26
2021
Q2
$16.2M Sell
358,555
-5,631
-2% -$250K 1.31% 31
2021
Q1
$17.6M Sell
364,186
-58,434
-14% -$3.04M 1.54% 28
2020
Q4
$22.8M Sell
422,620
-57,454
-12% -$2.6M 1.94% 15
2020
Q3
$17.7M Sell
480,074
-24,643
-5% -$916K 1.49% 24
2020
Q2
$15.6M Buy
504,717
+7,939
+2% +$220K 1.38% 31
2020
Q1
$13.7M Sell
496,778
-101,123
-17% -$3.03M 1.62% 20
2019
Q4
$17.5M Buy
+597,901
New +$14.2M 1.64% 23

Other funds holding NEO

Redwood Investments's NEO Position: Q1 2025 in Review

Redwood Investments sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 73,444 shares — an estimated $1.21M sold.

Redwood Investments first reported a position in NEO in Q4 2019 and held it in 14 quarters. The position peaked at $22.8M in Q4 2020. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Redwood Investments reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Redwood Investments sold 73,444 NeoGenomics shares in Q1 2025, an estimated $1.21M.
  • Redwood Investments first reported a position in NeoGenomics in Q4 2019 and held it in 14 quarters.
  • Redwood Investments's NeoGenomics position peaked at $22.8M in Q4 2020.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Redwood Investments's 13F filing for Q1 2025, filed 16 May 2025.